Grifols, S.A. (GRFS) Sees Strong Biopharma Growth Led by Gamunex and Yimmugo
Grifols, S.A. (GRFS) Sees Strong Biopharma Growth Led by Gamunex and Yimmugo...
Yahoo! Finance: News
More News
Can Asceniv Help ADMA Navigate the Current IG Market Challenges?
ADMA faces IG pricing pressure and reduced 2026 guidance, but Asceniv demand remains strong amid resilient patient utilization.
Zacks
Will the IG Market Challenges Affect ADMA Biologics Prospects in 2026?
ADMA cuts 2026 guidance after weak Bivigam sales and IG market pressure weigh on revenues amid rising competition and order volatility.
Zacks
Is it Time to Exit ADMA Biologics Stock After a 22% Monthly Plunge?
ADMA shares plunge after the company cuts 2026 guidance, citing pricing pressure, rising competition and elevated IG channel inventories.
Zacks
Will the Label Expansion of Asceniv Boost ADMA's Top-Line Growth?
ADMA stock in focus after FDA expands Asceniv's label to younger patients, boosting market reach and growth outlook amid rising demand.
Zacks
Wall Street Zen Downgrades Grifols (NASDAQ:GRFS) to Hold
Wall Street Zen cut shares of Grifols from a "buy" rating to a "hold" rating in a research report on Saturday...
MarketBeat
Grifols (GRFS) to Release Earnings on Thursday
Grifols (NASDAQ:GRFS) will be releasing its Q1 2026 earnings on Thursday, April 30. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-30-grifols-sa-stock...
MarketBeat
Will Asceniv Deliver for ADMA in the Upcoming Quarterly Results?
ADMA banks on surging Asceniv demand to sustain growth, supported by expanded plasma supply and broader coverage, which should drive continued gains into 2026.
Zacks
Does ADMA Biologics' Growth Story Outweigh Short-Seller Concerns?
ADMA stock slides after a short report sparks volatility, but management pushes back, citing strong Asceniv demand and steady fundamentals.
Zacks
Grifols, S.A. (NASDAQ:GRFS) Short Interest Update
Grifols, S.A. (NASDAQ:GRFS - Get Free Report) was the target of a significant drop in short interest in March. As of March 31st, there was short interest totaling 5,261,576 shares, a drop of 25.0...